The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pleural/pericardial effusion, ANA positive (DI lupus)
Publications
Minocycline-induced lupus: clinical features and response to rechallenge.
Rheumatology (Oxford, England) 2001 Mar;40;329-35 — 2001 Mar — 329-35
Minocycline induced autoimmune disease in rheumatoid arthritis: a missed diagnosis?
The Journal of rheumatology 2001 Feb;28;377-8 — 2001 Feb — 377-8
Respiratory distress due to minocycline-induced pulmonary lupus.
Chest 1999 May;115;1471-3 — 1999 May — 1471-3
Minocycline-induced lupus in adolescents.
Pediatrics 1998 May;101;926 — 1998 May — 926
Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature.
Archives of dermatology 1996 Aug;132;934-9 — 1996 Aug — 934-9
Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome.
BMJ (Clinical research ed.) 1996 Jan 20;312;169-72 — 1996 Jan 20 — 169-72